Gene · 8473
Papers4,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LigExtract: Large-scale Automated Identification of Ligands from Protein Structures in the Protein Data Bank. | Genomics Proteomics Bioinformatics | 2025 | 40036758 | PubTator, text mining | PubMed |
| New strategies to enhance the efficiency and precision of drug discovery. | Front Pharmacol | 2025 | 40008135 | PubTator, text mining | PubMed |
| Mannose Inhibits NSCLC Growth and Inflammatory Microenvironment by Regulating Gut Microbiota and Targeting OGT/hnRNP R/JUN/IL-8 Axis. | Int J Biol Sci | 2025 | 39990658 | PubTator, text mining | PubMed |
| O-GlcNAcAtlas 4.0: An Updated Protein O-GlcNAcylation Database with Site-specific Quantification. | J Mol Biol | 2025 | 39988118 | PubTator, text mining | PubMed |
| Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway. | Acta Pharmacol Sin | 2025 | 39984622 | PubTator, text mining | PubMed |
| Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis. | Cell Death Dis | 2025 | 39984455 | PubTator, text mining | PubMed |
| β-hydroxybutyrylation and O-GlcNAc modifications of STAT1 modulate antiviral defense in aging. | Cell Mol Immunol | 2025 | 39979583 | PubTator, text mining | PubMed |
| Mechanism of O-GlcNAcylation regulating liver lipid synthesis in mice through FASN. | FASEB J | 2025 | 39950311 | PubTator, text mining | PubMed |
| Multiomics analysis of O-GlcNAcylation in podocytes of diabetic kidney disease. | Diabetes Obes Metab | 2025 | 39950214 | PubTator, text mining | PubMed |
| Buckwheat protein-derived peptide ameliorates insulin resistance by directing O-linked N-acetylglucosamine transferase to regulate the SIRT1/PGC1α pathway. | Int J Biol Macromol | 2025 | 39947565 | PubTator, text mining | PubMed |
| Comparative analysis of senescence induction by different chemotherapeutic agents in HCT116 colon cancer cells. | Biochem Biophys Res Commun | 2025 | 39946980 | PubTator, text mining | PubMed |
| Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer. | Cancer Res | 2025 | 39937190 | PubTator, text mining | PubMed |
| Peimine inhibits cell proliferation and migration of breast cancer via regulating the O-GlcNAcylation of USP41. | Int Immunopharmacol | 2025 | 39923575 | PubTator, text mining | PubMed |
| FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy. | Nat Commun | 2025 | 39894887 | Swiss-Prot, curated | PubMed |
| Enhanced O-glycosylation site prediction using explainable machine learning technique with spatial local environment. | Bioinformatics | 2025 | 39878910 | PubTator, text mining | PubMed |
| Silencing of O-GlcNAc Transferase Attenuated O-GlcNAcylation and Metastatic Potentials of Melanoma Cells Through Suppression of Akt-NFκB Signaling Pathway. | Chembiochem | 2025 | 39878235 | PubTator, text mining | PubMed |
| The Impact of Modifiable Risk Factors on the Endothelial Cell Methylome and Cardiovascular Disease Development. | Front Biosci (Landmark Ed) | 2025 | 39862076 | PubTator, text mining | PubMed |
| O-GlcNAcylation of DJ-1 suppresses ferroptosis in renal cell carcinoma by affecting the transsulfuration pathway. | Int Immunopharmacol | 2025 | 39842141 | PubTator, text mining | PubMed |
| Live-cell FRET assay on the stoichiometry and affinity of the YAP complexes in MCF-7 cells. | Arch Biochem Biophys | 2025 | 39818347 | PubTator, text mining | PubMed |
| Biological characteristics, immune infiltration and drug prediction of PANoptosis related genes and possible regulatory mechanisms in inflammatory bowel disease. | Sci Rep | 2025 | 39814753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8473/papers?page=16